CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI, March 22, 2026 /PRNewswire/ -- Harbour BioMed (HKEX: 02142, the "Company"), a global biopharmaceutical company committed to the discovery and ...
APEX Part A data demonstrated durable maintenance of response at 52-weeks for every 3- and 6-months dosing, respectively, including:- 75% and 85% ...
It's my pleasure to be moderating this chat with the CEO of Voyager Therapeutics, Al Sandrock, who sure many folks know well from his current role and famous roles as prior. Al, maybe we can get into ...
Phase 1 data on TNX-4800 (long-acting anti-Borrelia OspA human monoclonal antibody) for the seasonal prevention of Lyme disease Wednesday, April 1: Animal and in vitro studies on TNX-801 (horsepox, ...
XTX501, a potential best-in-class bispecific PD-1 / masked IL-2, on track for planned IND submission in mid-2026 and Phase 1 initiation in the ...
Techno-Science.net on MSN
Dietary supplements: alert on sleep and adolescent growth
To cope with busy schedules, many young people are looking for solutions to increase their energy and sports performance. But ...
APEX Part A data demonstrated durable maintenance of response at 52-weeks for every 3- and 6-months dosing, respectively, ...
A total of 18 companies in New Mexico will receive funding from the state to hire, train, and upskill 398 workers. The New Mexico Economic Development Department’s Job ...
The artwork was apparently created early in the development process for experimental purposes and was not intended to make it ...
The new flagship CPU launched just 22% behind the Core i9-14900K despite having only 12 cores and offers similar ...
So evaluating the Seattle Seahawks’ decision to sign reigning NFL Offensive Player of the Year Jaxon Smith-Njigba to a ...
Backed by partner Sanofi, Earendil will expand the utility of its AI-driven drug discovery platform, while progressing its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results